Literature DB >> 11257465

Fibrinogen is an efficient antioxidant.

R M. Olinescu1, F A. Kummerow.   

Abstract

Fibrinogen has been included among the risk factors for vascular disease. Fibrinogen belongs with albumin, ceruloplasmin and transferrin to an acute phase protein group in the plasma. Albumin, ceruloplasmin and transferrin are already recognized as natural antioxidants. In the present study we used three different oxygen generating systems in order to test whether fibrinogen is able to act as an antioxidant in an in vitro system. We used 1) pyrogallol auto-oxidation, 2) the reaction catalysed by xanthine oxidase coupled with the reduction of ferricytochrome c and 3) chemiluminescence. We found that in a dose-dependent manner fibrinogen inhibited superoxide generation (pyrogallol and xanthine-xanthine oxidase reactions), ferrous ion oxidation and hydroxyl radical dependent degradation (of deoxyribose). Fibrinogen also inhibited LDL oxidation (copper and azo compound-induced), hydrogen peroxide oxidation and chemiluminescence produced by polymorphonuclear leukocytes. Fibrinogen, albumin, ceruloplasmin and transferrin act as a supplementary antioxidant defense mechanism against oxidative stress arising from inflammatory conditions.

Entities:  

Year:  2001        PMID: 11257465     DOI: 10.1016/s0955-2863(00)00147-9

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  4 in total

1.  Mapping Atheroprotective Functions and Related Proteins/Lipoproteins in Size Fractionated Human Plasma.

Authors:  Debi K Swertfeger; Hailong Li; Sandra Rebholz; Xiaoting Zhu; Amy S Shah; W Sean Davidson; Long J Lu
Journal:  Mol Cell Proteomics       Date:  2017-02-21       Impact factor: 5.911

2.  Effects of cupric chloride on coagulation in human plasma: role of fibrinogen.

Authors:  Vance G Nielsen; Timothy D Ward; Paul M Ford
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

3.  Eryptosis as a marker of Parkinson's disease.

Authors:  Etheresia Pretorius; Albe C Swanepoel; Antoinette V Buys; Natasha Vermeulen; Wiebren Duim; Douglas B Kell
Journal:  Aging (Albany NY)       Date:  2014-10       Impact factor: 5.682

4.  Altered clot microstructure detected in obstructive sleep apnoea hypopnoea syndrome.

Authors:  Lindsay D'Silva; Maria Wilczynska; Keir Lewis; Matthew Lawrence; Karl Hawkins; Rhodri Williams; Sophia Stanford; Simon Davidson; Keith Morris; Adrian Evans
Journal:  Sleep Sci       Date:  2016-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.